Clinical Trial Update: Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effects of interleukin-1 beta on low testosterone in men with obesity and metabolic syndrome; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Metabolic Syndrome
• Obesity

Drugs mentioned

• Interleukin-1 beta (interleukin-1 beta)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Hypogonadism, Metabolic Syndrome X | Phase 3 | Status: COMPLETED